Equity Profile

IQV

IQVIA Holdings Inc.

Health CareLife Sciences Tools & Services$39.8B

Jul21Tue

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

IQVIA Holdings Inc. operates in the health care sector, providing essential data and analytics services for life sciences....

Key Metrics to Watch

EPS

Earnings per share is a critical measure of profitability and will indicate how well the company is managing costs and generating income.

$3.27

Revenue

Revenue growth reflects the company's ability to expand its customer base and service offerings, which is vital for long-term success.

$4.4B

Wall Street expectations, options signals, track record, and call prep available with Pro.

IQV Q2-2026 Earnings Preview

Context

Company Snapshot

IQVIA Holdings Inc. operates in the health care sector, providing essential data and analytics services for life sciences. Their work supports pharmaceutical companies and healthcare providers in improving patient outcomes and operational efficiencies, making them a key player in the evolving health care landscape.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+11.71%

Avg Stock Reaction

+2.48%

Last Quarter Recap

In Q1-2026, IQVIA reported an EPS of $2.90, exceeding expectations by 15.68%. The stock rose 9.62% the following day, reflecting positive market sentiment.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect IQVIA to continue its strong performance with an EPS of $3.27 and revenue of $4.4B. The market is closely watching for any signs of growth or challenges in their core business.

Bull Case

If IQVIA beats EPS estimates, it could signal robust demand for their services and lead to increased investor confidence, potentially driving the stock higher.

Bear Case

Conversely, if the company fails to meet expectations, it may raise concerns about growth prospects and operational challenges, leading to a negative market reaction.

Key Metrics to Watch

EPS

$3.27

Earnings per share is a critical measure of profitability and will indicate how well the company is managing costs and generating income.

Revenue

$4.4B

Revenue growth reflects the company's ability to expand its customer base and service offerings, which is vital for long-term success.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will IQVIA's EPS exceed the consensus estimate of $3.27?

A beat on EPS would reinforce the company's growth narrative and could lead to a positive stock reaction.

What insights will management provide regarding revenue growth trends?

Understanding revenue drivers is crucial for assessing the company's future performance and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate IQVIA's ability to leverage its data analytics capabilities for accelerated growth, especially in emerging markets.

Supporting Evidence

The company's recent performance has consistently exceeded EPS estimates, indicating strong operational execution.

Options pricing suggests a larger move than historical averages, indicating potential for a significant surprise.

Key Risk

If revenue growth significantly outpaces expectations, it could shift the market's perception of IQVIA's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will either validate the company's growth trajectory or highlight potential weaknesses.

Bull Confirmed If

An EPS of $3.35 or higher would confirm strong demand and operational efficiency.

Bear Confirmed If

An EPS below $3.20 would raise concerns about growth and profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±16.03%

Historical Avg

±7.3%

Pricing rich

The options market is pricing in a significant potential move, suggesting that investors anticipate volatility around the earnings report.

Options are pricing ±16.0% while IQV has averaged ±7.3% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

51.6%

Calls (204K)P/C Ratio: 0.32Puts (69K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If IQVIA beats expectations, history suggests the stock could rise by about 2.48% on the following day, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction, reflecting cautious sentiment from investors.

Miss

A miss could lead to a decline, with historical patterns indicating an average drop of around 4.01% when expectations are not met.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·1 sell

Members

House only

Est. Notional

$50,001.00–$100,000.00

disclosed dollar ranges

Most Active Members

R-OKKevin HernRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new client acquisitions or partnerships.
2Management's outlook on market demand for data analytics in health care.
3Insights into cost management strategies and their impact on margins.
4Discussion of any challenges faced in recent quarters and how they are being addressed.
5Any commentary on competitive dynamics within the life sciences tools and services industry.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

ICICI Bank Limited

Company Snapshot

IQVIA Holdings Inc. operates in the health care sector, providing essential data and analytics services for life sciences....

Key Metrics to Watch

EPS

Earnings per share is a critical measure of profitability and will indicate how well the company is managing costs and generating income.

$3.27

Revenue

Revenue growth reflects the company's ability to expand its customer base and service offerings, which is vital for long-term success.

$4.4B

Wall Street expectations, options signals, track record, and call prep available with Pro.

IQV Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+11.71%

Avg Stock Reaction

+2.48%

Last Quarter Recap

In Q1-2026, IQVIA reported an EPS of $2.90, exceeding expectations by 15.68%. The stock rose 9.62% the following day, reflecting positive market sentiment.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect IQVIA to continue its strong performance with an EPS of $3.27 and revenue of $4.4B. The market is closely watching for any signs of growth or challenges in their core business.

Bull Case

If IQVIA beats EPS estimates, it could signal robust demand for their services and lead to increased investor confidence, potentially driving the stock higher.

Bear Case

Conversely, if the company fails to meet expectations, it may raise concerns about growth prospects and operational challenges, leading to a negative market reaction.

Key Metrics to Watch

EPS

$3.27

Earnings per share is a critical measure of profitability and will indicate how well the company is managing costs and generating income.

Revenue

$4.4B

Revenue growth reflects the company's ability to expand its customer base and service offerings, which is vital for long-term success.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will IQVIA's EPS exceed the consensus estimate of $3.27?

A beat on EPS would reinforce the company's growth narrative and could lead to a positive stock reaction.

What insights will management provide regarding revenue growth trends?

Understanding revenue drivers is crucial for assessing the company's future performance and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate IQVIA's ability to leverage its data analytics capabilities for accelerated growth, especially in emerging markets.

Supporting Evidence

The company's recent performance has consistently exceeded EPS estimates, indicating strong operational execution.

Options pricing suggests a larger move than historical averages, indicating potential for a significant surprise.

Key Risk

If revenue growth significantly outpaces expectations, it could shift the market's perception of IQVIA's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will either validate the company's growth trajectory or highlight potential weaknesses.

Bull Confirmed If

An EPS of $3.35 or higher would confirm strong demand and operational efficiency.

Bear Confirmed If

An EPS below $3.20 would raise concerns about growth and profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±16.03%

Historical Avg

±7.3%

Pricing rich

The options market is pricing in a significant potential move, suggesting that investors anticipate volatility around the earnings report.

Options are pricing ±16.0% while IQV has averaged ±7.3% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

51.6%

Calls (204K)P/C Ratio: 0.32Puts (69K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If IQVIA beats expectations, history suggests the stock could rise by about 2.48% on the following day, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction, reflecting cautious sentiment from investors.

Miss

A miss could lead to a decline, with historical patterns indicating an average drop of around 4.01% when expectations are not met.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·1 sell

Members

House only

Est. Notional

$50,001.00–$100,000.00

disclosed dollar ranges

Most Active Members

R-OKKevin HernRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new client acquisitions or partnerships.
2Management's outlook on market demand for data analytics in health care.
3Insights into cost management strategies and their impact on margins.
4Discussion of any challenges faced in recent quarters and how they are being addressed.
5Any commentary on competitive dynamics within the life sciences tools and services industry.